Dysregulation of Th17 cells during the early post-transplant period in patients under calcineurin inhibitor based immunosuppression

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Chung, Byung Ha ^a   Kim, Kyoung Woon ^a   Kim, Bo Mi ^a   Piao, Shang Guo ^a   Lim, Sun Woo ^a   Choi, Bum Soon ^a   Park, Cheol Whee ^a   Kim, Yong Soo ^a   Cho, Mi La ^a   Yang, Chul Woo ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 1BETA; MESSENGER RNA; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ADULT; ARTICLE; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG SCREENING; EFFECTOR CELL; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DYSREGULATION; IMMUNOREACTIVITY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; KIDNEY ALLOGRAFT; KIDNEY FAILURE; LEUKOPENIA; LIVING DONOR; MALE; POSTOPERATIVE PERIOD; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL;

ADULT; BIOLOGICAL MARKERS; CALCINEURIN; CD4-POSITIVE T-LYMPHOCYTES; ENZYME INHIBITORS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION; HUMANS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; TACROLIMUS; TH17 CELLS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84864327434     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042011     Document Type: Article

References (33)

1. Calvo-Turrubiartes M, Romano-Moreno S, Garcia-Hernandez M, Chevaile-Ramos JA, Layseca-Espinosa E, et al. ((2009)) Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level. Transpl Immunol 21:: 43--49.
2. Warrens AN, ((2002)) Pharmacological control of the immune response in renal transplantation. BJU Int 90:: 784--791.
3. Halloran PF, ((2004)) Immunosuppressive drugs for kidney transplantation. N Engl J Med 351:: 2715--2729.
4. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, et al. ((2000)) Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342:: 605--612.
5. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B, ((2004)) Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 4:: 378--383.
6. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB, ((2002)) Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 346:: 580--590.
7. Korn T, Bettelli E, Oukka M, Kuchroo VK, ((2009)) IL-17 and Th17 Cells. Annu Rev Immunol 27:: 485--517.
8. Steinman L, ((2007)) A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13:: 139--145.
9. Lee YK, Mukasa R, Hatton RD, Weaver CT, ((2009)) Developmental plasticity of Th17 and Treg cells. Curr Opin Immunol 21:: 274--280.
10. Nistala K, Wedderburn LR, ((2009)) Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis. Rheumatology (Oxford) 48:: 602--606.
11. Ochs HD, Oukka M, Torgerson TR, ((2009)) TH17 cells and regulatory T cells in primary immunodeficiency diseases. J Allergy Clin Immunol 123:: 977--983; quiz 984-975.
12. Eastaff-Leung N, Mabarrack N, Barbour A, Cummins A, Barry S, ((2010)) Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J Clin Immunol 30:: 80--89.
13. Loong CC, Lin CY, Lui WY, ((2000)) Expression of interleukin-17 as a predictive parameter in acute renal allograft rejection. Transplantation proceedings 32:: 1773--1773.
14. Hsieh HG, Loong CC, Lui WY, Chen A, Lin CY, ((2001)) IL-17 expression as a possible predictive parameter for subclinical renal allograft rejection. Transpl Int 14:: 287--298.
15. Mitchell P, Afzali B, Lombardi G, Lechler RI, ((2009)) The T helper 17-regulatory T cell axis in transplant rejection and tolerance. Curr Opin Organ Transplant 14:: 326--331.
16. Crispim JC, Grespan R, Martelli-Palomino G, Rassi DM, Costa RS, et al. ((2009)) Interleukin-17 and kidney allograft outcome. Transplant Proc 41:: 1562--1564.
17. San Segundo D, Lopez-Hoyos M, Fernandez-Fresnedo G, Benito MJ, Ruiz JC, et al. ((2008)) T(H)17 versus Treg cells in renal transplant candidates: effect of a previous transplant. Transplant Proc 40:: 2885--2888.
18. Alvarez-Lara MA, Carracedo J, Ramirez R, Martin-Malo A, Rodriguez M, et al. ((2004)) The imbalance in the ratio of Th1 and Th2 helper lymphocytes in uraemia is mediated by an increased apoptosis of Th1 subset. Nephrol Dial Transplant 19:: 3084--3090.
19. Rentenaar RJ, van Diepen FN, Meijer RT, Surachno S, Wilmink JM, et al. ((2002)) Immune responsiveness in renal transplant recipients: mycophenolic acid severely depresses humoral immunity in vivo. Kidney Int 62:: 319--328.
20. Takatsuki M, Uemoto S, Inomata Y, Sakamoto S, Hayashi M, et al. ((2001)) Analysis of alloreactivity and intragraft cytokine profiles in living donor liver transplant recipients with graft acceptance. Transpl Immunol 8:: 279--286.
21. Weimer R, Melk A, Daniel V, Friemann S, Padberg W, et al. ((2000)) Switch from cyclosporine A to tacrolimus in renal transplant recipients: impact on Th1, Th2, and monokine responses. Hum Immunol 61:: 884--897.
22. Syrjala SO, Keranen MA, Tuuminen R, Nykanen AI, Tammi M, et al. ((2010)) Increased Th17 rather than Th1 alloimmune response is associated with cardiac allograft vasculopathy after hypothermic preservation in the rat. J Heart Lung Transplant 29:: 1047--1057.
23. Park H, Li Z, Yang XO, Chang SH, Nurieva R, et al. ((2005)) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6:: 1133--1141.
24. Weaver CT, Hatton RD, ((2009)) Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective. Nat Rev Immunol 9:: 883--889.
25. Lohr J, Knoechel B, Wang JJ, Villarino AV, Abbas AK, ((2006)) Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J Exp Med 203:: 2785--2791.
26. Mas VR, Archer KJ, Scian M, Maluf DG, ((2010)) Molecular pathways involved in loss of graft function in kidney transplant recipients. Expert Rev Mol Diagn 10:: 269--284.
27. Mas V, Maluf D, Archer K, Yanek K, Mas L, et al. ((2007)) Establishing the molecular pathways involved in chronic allograft nephropathy for testing new noninvasive diagnostic markers. Transplantation 83:: 448--457.
28. Braun RK, Martin A, Shah S, Iwashima M, Medina M, et al. ((2010)) Inhibition of bleomycin-induced pulmonary fibrosis through pre-treatment with collagen type V. J Heart Lung Transplant 29:: 873--880.
29. Decraene A, Willems-Widyastuti A, Kasran A, De Boeck K, Bullens DM, et al. ((2010)) Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients. Respir Res 11:: 177.
30. Hammerich L, Heymann F, Tacke F, ((2011)) Role of IL-17 and Th17 cells in liver diseases. Clin Dev Immunol 2011:: 345803.
31. Deteix C, Attuil-Audenis V, Duthey A, Patey N, McGregor B, et al. ((2010)) Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection. J Immunol 184:: 5344--5351.
32. Chung BH, OH HJ, Piao SG, Sun IO, Kang SH, et al. ((2011)) Higher infiltration by Th17 cells compared with regulatory T cells is associated with severe acute T-cell-mediated rejection. Exp Mol Med.
33. Abadja F, Atemkeng S, Alamartine E, Berthoux F, Mariat C, ((2011)) Impact of mycophenolic Acid and tacrolimus on th17-related immune response. Transplantation 92:: 396--403.